Liquidia to Participate in the Jefferies London Healthcare Conference

Rhea-AI Summary

Liquidia Corporation (NASDAQ: LQDA) has announced that its Chief Financial Officer, Michael Kaseta, will speak at the Jefferies 2021 Virtual London Healthcare Conference from November 16-19, 2021. The insightful fireside chat will be available on-demand from 8:00 a.m. GMT on November 18, 2021, for registered participants. Investors can access the webcast on Liquidia's website, which will remain archived for 30 days post-event. Liquidia focuses on the development of innovative therapies for pulmonary hypertension, including YUTREPIA™, an inhalation powder treatment.

MORRISVILLE, N.C., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that Mr. Michael Kaseta, Chief Financial Officer of Liquidia, will provide an update on the company's business during a fireside chat at the Jefferies 2021 Virtual London Healthcare Conference being held November 16-19, 2021 . The fireside chat will be available to registered participants on-demand beginning at 8:00 a.m. GMT on November 18, 2021.

A webcast of the event will be available on the investors section of Liquidia’s website at https://liquidia.com/investors/events-and-presentations, and will be archived for 30 days following the event.

About Liquidia Corporation
Liquidia Corporation is a biopharmaceutical company focused on the development and commercialization of products in pulmonary hypertension and other applications of its PRINT® Technology. The company operates through its two wholly owned subsidiaries, Liquidia Technologies, Inc. and Liquidia PAH, LLC. Liquidia Technologies has developed YUTREPIA™ (treprostinil) inhalation powder for the treatment of pulmonary arterial hypertension (PAH). Liquidia PAH provides the commercialization for rare disease pharmaceutical products, such as generic Treprostinil Injection. For more information, please visit www.liquidia.com.

Contact Information

Media & Investors:
Jason Adair
Vice President, Corporate Development and Strategy
919.328.4400
jason.adair@liquidia.com

FAQ

When is Liquidia's fireside chat at the Jefferies 2021 Virtual London Healthcare Conference?

Liquidia's fireside chat is scheduled for November 18, 2021, available on-demand from 8:00 a.m. GMT.

Who is speaking for Liquidia at the Jefferies Conference?

Michael Kaseta, the Chief Financial Officer of Liquidia, will provide the business update.

Where can I watch Liquidia's fireside chat?

The fireside chat will be accessible on Liquidia's investor website and archived for 30 days after the event.

What is the main focus of Liquidia Corporation?

Liquidia Corporation specializes in developing treatments for pulmonary hypertension and employs PRINT® Technology.

What products does Liquidia offer for pulmonary hypertension?

Liquidia has developed YUTREPIA™, an inhalation powder for treating pulmonary arterial hypertension.